Literature DB >> 8306772

Phenytoin toxicity associated with hypoalbuminemia in critically ill patients.

J Lindow1, E F Wijdicks.   

Abstract

Four critically ill patients developed phenytoin toxicity. Hypoalbuminemia or concomitant displacing drugs resulted in an increased fraction of unbound drug. Clinical findings included gradual decrease in level of consciousness and cerebellar signs. Marked phenytoin toxicity can occur in critically ill patients with hypoalbuminemia and can often be detected only by direct measurement of free phenytoin levels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8306772     DOI: 10.1378/chest.105.2.602

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

Review 1.  Protein based therapeutic delivery agents: Contemporary developments and challenges.

Authors:  Liming Yin; Carlo Yuvienco; Jin Kim Montclare
Journal:  Biomaterials       Date:  2017-04-21       Impact factor: 12.479

2.  Validation of a free phenytoin assay on Cobas c501 analyzer using calibrators from Cobas Integra free phenytoin assay by comparing its performance with fluorescence polarization immunoassay for free phenytoin on the TDx analyzer.

Authors:  Amitava Dasgupta; Bonnette Davis; Loretta Chow
Journal:  J Clin Lab Anal       Date:  2013-01       Impact factor: 2.352

3.  Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.

Authors:  Kim Vanstraelen; Joost Wauters; Ine Vercammen; Henriette de Loor; Johan Maertens; Katrien Lagrou; Pieter Annaert; Isabel Spriet
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

4.  Diagnosis and Treatment of Nonconvulsive Status Epilepticus in an Intensive Care Unit Setting.

Authors:  Stephan J. Rüegg; Marc A. Dichter
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

Review 5.  The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.

Authors:  Marta Ulldemolins; Jason A Roberts; Jordi Rello; David L Paterson; Jeffrey Lipman
Journal:  Clin Pharmacokinet       Date:  2011-02       Impact factor: 6.447

6.  When less is more: a case of phenytoin toxicity.

Authors:  Kit Robertson; Conrad Brice von Stempel; Ian Arnold
Journal:  BMJ Case Rep       Date:  2013-03-27

7.  Correlation between measured and calculated free phenytoin serum concentration in neurointensive care patients with hypoalbuminemia.

Authors:  Seyyede-Sareh Javadi; Reza Mahjub; Abbas Taher; Younes Mohammadi; Maryam Mehrpooya
Journal:  Clin Pharmacol       Date:  2018-12-13

8.  Differences between the measured and calculated free serum phenytoin concentrations in epileptic patients.

Authors:  Ji-Man Hong; Young-Chul Choi; Won-Joo Kim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

9.  A Novel Correction Equation Avoids High-Magnitude Errors in Interpreting Therapeutic Drug Monitoring of Phenytoin Among Critically Ill Patients.

Authors:  Megan E Barra; Kristy M Phillips; David Y Chung; Eric S Rosenthal
Journal:  Ther Drug Monit       Date:  2020-08       Impact factor: 3.118

10.  Total Phenytoin concentration is not well correlated with active free drug in critically-ill head trauma patients.

Authors:  Kourosh Sadeghi; Farin Hadi; Arezoo Ahmadi; Hadi Hamishehkar; Mohammad-Taghi Beigmohammadi; Ata Mahmoodpoor; Mohammad Reza Rouini; Shirin Farhudi; Narjes Hendoui; Atabak Najafi; Mojtaba Mojtahedzadeh
Journal:  J Res Pharm Pract       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.